Steward Partners Investment Advisory’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
ACH
GKIM
HRCM
PIM
FGP
Steward Partners Investment Advisory's TNDM Position: Q3 2025 in Review
Steward Partners Investment Advisory sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 130 shares — an estimated $2.42K sold.
Steward Partners Investment Advisory first reported a position in TNDM in Q4 2019 and held it in 19 quarters. The position peaked at $63.5K in Q1 2021. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.
- Steward Partners Investment Advisory reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
- Steward Partners Investment Advisory sold 130 Tandem Diabetes Care shares in Q3 2025, an estimated $2.42K.
- Steward Partners Investment Advisory first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 19 quarters.
- Steward Partners Investment Advisory's Tandem Diabetes Care position peaked at $63.5K in Q1 2021.
- 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.
Based on Steward Partners Investment Advisory's 13F filing for Q3 2025, filed 12 Nov 2025.